Kidney cancer
Would you like to receive a message when there is new research about kidney cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you receive a notification as soon as new research on Renal cell carcinoma is published. View what Premium costs.
Publications and studies (2200)
- Identification of IRF-associated molecular subtypes in clear cell renal cell carcinoma to characterize immunological characteristics and guide therapy. (2023/01/19) ♡
- Corrigendum: Development of a phagocytosis-dependent gene signature to predict prognosis and response to checkpoint inhibition in clear-cell renal cell carcinoma. (2023/01/19) ♡
- Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition. (2023/01/17) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Molecular genetics and therapeutic advances in renal carcinoma. (2023/01/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Renal cell carcinoma of different pathological types in bilateral native kidneys of a kidney transplant recipient: A case report and literature review. (2023/01/16) ♡
- A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis. (2023/01/16) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Immune checkpoint inhibitor-related vitiligo-like depigmentation in non-melanoma advanced cancer: A report of three cases and a pooled analysis of individual patient data. (2023/01/13) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Relative Risk of Bladder and Kidney Cancer in Lynch Syndrome: Systematic Review and Meta-Analysis. (2023/01/13) ♡
- LGALS1 was related to the prognosis of clear cell renal cell carcinoma identified by weighted correlation gene network analysis combined with differential gene expression analysis. (2023/01/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management. (2023/01/12) ♡
- SCCPMD: Probability matrix decomposition method subject to corrected similarity constraints for inferring long non-coding RNA-disease associations. (2023/01/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CircCCDC66: Emerging roles and potential clinical values in malignant tumors. (2023/01/09) ♡
- PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers. (2023/01/09) ♡
- Prognostic significance of CKAP2L expression in patients with clear cell renal cell carcinoma. (2023/01/09) ♡
- Angiomyolipoma of the kidney-Clinicopathological analysis of 52 cases. (2023/01/09) ♡
- A nomogram for predicting cancer-specific survival and overall survival in elderly patients with nonmetastatic renal cell carcinoma. (2023/01/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune-related ureteritis and cystitis induced by immune checkpoint inhibitors: Case report and literature review. (2023/01/06) ♡
- A clinical prediction model for predicting the risk of liver metastasis from renal cell carcinoma based on machine learning. (2023/01/05) ♡
- Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model. (2023/01/04) ♡
- Up-regulated PIF1 predicts poor clinical outcomes and correlates with low immune infiltrates in clear cell renal cell carcinoma. (2023/01/04) ♡
- A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs). (2023/01/04) ♡
- Development and validation of A CT-based radiomics nomogram for prediction of synchronous distant metastasis in clear cell renal cell carcinoma. (2023/01/04) ♡
- Complete response to an anti-programmed cell death 1 antibody following a combination therapy of an anti-programmed cell death ligand 1 antibody and a tyrosine kinase inhibitor for metastatic renal cell carcinoma. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Extranodal Rosai-Dorfman disease: A rare mimicker of metastatic renal cell carcinoma. (2023/01/01) ♡
- Dissection of tumor antigens and immune landscape in clear cell renal cell carcinoma: Preconditions for development and precision medicine of mRNA vaccine. (2023/01/01) ♡
- Laparoscopic radical nephrectomy in Trendelenburg position - technical modifications for a pelvic kidney. (2023/01/01) ♡
- Bladder and Kidney Cancer Diagnosis and Survival Increase With Medicare Eligibility at Age 65. (2023/01/01) ♡
- Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting System. (2023/01/01) ♡
- The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness. (2023/01/01) ♡
- Prognostic Value of Sarcopenia and Albumin in the Surgical Management of Localized Renal Cell Carcinoma. (2023/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer. (2023/01/01) ♡
- Geriatric Nutritional Risk Index as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated with Nivolumab. (2023/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fatty acid transport proteins (FATPs) in cancer. (2023/01/01) ♡
- The geriatric nutritional risk index predicts complications after nephrectomy for renal cancer. (2023/01/01) ♡
- [A SUCCESSFUL CASE OF LYMPHATIC EMBOLIZATION IN A PATIENT WITH PROLONGED LYMPHATIC LEAKAGE AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CANCER]. (2023/01/01) ♡
- Review: Mammalian Target of Rapamycin (mTOR) Pathway Is Critical in Developing Most Renal Cell Tumors. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Co-administration of pazopanib and enteral nutrition with omega-3 fatty acids as a safety issue in a patient treated for metastatic clear cell renal cancer: A case report. (2023/01/01) ♡
- The impact of nutritional status and changes of body composition on the prognosis of metastatic renal cell carcinoma patients. (2023/01/01) ♡
- Activity of cabozantinib in further line treatment of metastatic clear cell renal cell carcinoma. Real-world experience in a single-center retrospective study. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Endobronchial localization - arena of two tumors: a case report. (2022/12/31) ♡
- Renal carcinoma with metastatic spread in a tiger (Panthera tigris): morphological and immunohistochemical study. (2022/12/31) ♡
- Immunotherapy for Urological Tumors on YouTube(TM): An Information-Quality Analysis. (2022/12/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Crescentic Fibrillary Glomerulonephritis in the Setting of Immune Checkpoint Inhibitor Therapy: A Report of Two Cases. (2022/12/30) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Relationship between Typical Environmental Endocrine Disruptors and Kidney Disease. (2022/12/29) ♡
- Multi-Omics Approach Reveals Redox Homeostasis Reprogramming in Early-Stage Clear Cell Renal Cell Carcinoma. (2022/12/29) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Rare Case of Renal Cell Carcinoma With Inferior Vena Cava Invasion: A Life-Threatening Complication. (2022/12/26) ♡
- Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma. (2022/12/26) ♡
- Screening of autoantibodies as biomarkers in the serum of renal cancer patients based on human proteome microarray. (2022/12/25) ♡
- Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma. (2022/12/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Klebsiella pneumoniae Infection as a Mimicker of Multiple Metastatic Lesions. (2022/12/18) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.